nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—CYP2D6—Hydroxyurea—head and neck cancer	0.248	0.378	CbGbCtD
Efavirenz—CYP1A2—Fluorouracil—head and neck cancer	0.115	0.175	CbGbCtD
Efavirenz—CYP2C9—Fluorouracil—head and neck cancer	0.104	0.158	CbGbCtD
Efavirenz—CYP2D6—Vinblastine—head and neck cancer	0.0878	0.134	CbGbCtD
Efavirenz—CYP3A4—Vinblastine—head and neck cancer	0.0559	0.0851	CbGbCtD
Efavirenz—CYP3A4—Docetaxel—head and neck cancer	0.046	0.0701	CbGbCtD
Efavirenz—Skin hyperpigmentation—Hydroxyurea—head and neck cancer	0.00547	0.0175	CcSEcCtD
Efavirenz—Eruption—Hydroxyurea—head and neck cancer	0.00528	0.0169	CcSEcCtD
Efavirenz—Neuritis—Vinblastine—head and neck cancer	0.00477	0.0153	CcSEcCtD
Efavirenz—Blister—Hydroxyurea—head and neck cancer	0.00451	0.0144	CcSEcCtD
Efavirenz—Hepatotoxicity—Hydroxyurea—head and neck cancer	0.00421	0.0135	CcSEcCtD
Efavirenz—Rash generalised—Docetaxel—head and neck cancer	0.00397	0.0127	CcSEcCtD
Efavirenz—Skin hyperpigmentation—Fluorouracil—head and neck cancer	0.00393	0.0126	CcSEcCtD
Efavirenz—Bone pain—Vinblastine—head and neck cancer	0.00372	0.0119	CcSEcCtD
Efavirenz—Nail disorder—Fluorouracil—head and neck cancer	0.00361	0.0115	CcSEcCtD
Efavirenz—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.00344	0.011	CcSEcCtD
Efavirenz—Ulcer—Hydroxyurea—head and neck cancer	0.00344	0.011	CcSEcCtD
Efavirenz—Creatinine increased—Hydroxyurea—head and neck cancer	0.00341	0.0109	CcSEcCtD
Efavirenz—Blister—Fluorouracil—head and neck cancer	0.00325	0.0104	CcSEcCtD
Efavirenz—Skin exfoliation—Hydroxyurea—head and neck cancer	0.0031	0.00992	CcSEcCtD
Efavirenz—Necrosis—Fluorouracil—head and neck cancer	0.00298	0.00953	CcSEcCtD
Efavirenz—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.00295	0.00944	CcSEcCtD
Efavirenz—Skin hyperpigmentation—Docetaxel—head and neck cancer	0.00284	0.00908	CcSEcCtD
Efavirenz—Eruption—Docetaxel—head and neck cancer	0.00275	0.00878	CcSEcCtD
Efavirenz—Speech disorder—Fluorouracil—head and neck cancer	0.00272	0.0087	CcSEcCtD
Efavirenz—Hepatic failure—Hydroxyurea—head and neck cancer	0.00263	0.00839	CcSEcCtD
Efavirenz—Parosmia—Docetaxel—head and neck cancer	0.0026	0.00832	CcSEcCtD
Efavirenz—Nail disorder—Docetaxel—head and neck cancer	0.0026	0.00832	CcSEcCtD
Efavirenz—Renal failure acute—Hydroxyurea—head and neck cancer	0.00256	0.00817	CcSEcCtD
Efavirenz—Ulcer—Fluorouracil—head and neck cancer	0.00247	0.00791	CcSEcCtD
Efavirenz—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.00247	0.00789	CcSEcCtD
Efavirenz—Neuralgia—Docetaxel—head and neck cancer	0.00243	0.00777	CcSEcCtD
Efavirenz—Inflammation—Fluorouracil—head and neck cancer	0.00241	0.00771	CcSEcCtD
Efavirenz—Neuritis—Docetaxel—head and neck cancer	0.00226	0.00723	CcSEcCtD
Efavirenz—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00221	0.00707	CcSEcCtD
Efavirenz—Hepatotoxicity—Docetaxel—head and neck cancer	0.00219	0.00699	CcSEcCtD
Efavirenz—Necrosis—Docetaxel—head and neck cancer	0.00215	0.00688	CcSEcCtD
Efavirenz—Breast disorder—Hydroxyurea—head and neck cancer	0.00213	0.00682	CcSEcCtD
Efavirenz—Rash maculo-papular—Fluorouracil—head and neck cancer	0.00213	0.0068	CcSEcCtD
Efavirenz—Pancytopenia—Vinblastine—head and neck cancer	0.00212	0.00679	CcSEcCtD
Efavirenz—Euphoric mood—Fluorouracil—head and neck cancer	0.00201	0.00643	CcSEcCtD
Efavirenz—Pancreatitis—Hydroxyurea—head and neck cancer	0.002	0.00639	CcSEcCtD
Efavirenz—Depression—Vinblastine—head and neck cancer	0.00199	0.00636	CcSEcCtD
Efavirenz—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00196	0.00627	CcSEcCtD
Efavirenz—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00195	0.00625	CcSEcCtD
Efavirenz—Pancytopenia—Hydroxyurea—head and neck cancer	0.00194	0.00619	CcSEcCtD
Efavirenz—CYP1A2—Arylamine metabolism—NAT2—head and neck cancer	0.00194	0.0635	CbGpPWpGaD
Efavirenz—Infestation NOS—Hydroxyurea—head and neck cancer	0.00182	0.00581	CcSEcCtD
Efavirenz—Infestation—Hydroxyurea—head and neck cancer	0.00182	0.00581	CcSEcCtD
Efavirenz—Drowsiness—Hydroxyurea—head and neck cancer	0.00182	0.00581	CcSEcCtD
Efavirenz—Amnesia—Fluorouracil—head and neck cancer	0.00181	0.00578	CcSEcCtD
Efavirenz—Blood bilirubin increased—Docetaxel—head and neck cancer	0.00179	0.00571	CcSEcCtD
Efavirenz—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00178	0.0057	CcSEcCtD
Efavirenz—Hypoaesthesia—Vinblastine—head and neck cancer	0.00178	0.00569	CcSEcCtD
Efavirenz—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00178	0.00568	CcSEcCtD
Efavirenz—Bone pain—Docetaxel—head and neck cancer	0.00176	0.00564	CcSEcCtD
Efavirenz—Inflammation—Docetaxel—head and neck cancer	0.00174	0.00557	CcSEcCtD
Efavirenz—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00172	0.0055	CcSEcCtD
Efavirenz—Influenza like illness—Docetaxel—head and neck cancer	0.00164	0.00524	CcSEcCtD
Efavirenz—Hallucination—Hydroxyurea—head and neck cancer	0.00162	0.00519	CcSEcCtD
Efavirenz—Skin exfoliation—Docetaxel—head and neck cancer	0.00161	0.00515	CcSEcCtD
Efavirenz—Ataxia—Fluorouracil—head and neck cancer	0.0016	0.00511	CcSEcCtD
Efavirenz—Neuropathy—Docetaxel—head and neck cancer	0.00159	0.00507	CcSEcCtD
Efavirenz—Alopecia—Vinblastine—head and neck cancer	0.00158	0.00506	CcSEcCtD
Efavirenz—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00152	0.00486	CcSEcCtD
Efavirenz—Lightheadedness—Docetaxel—head and neck cancer	0.00151	0.00483	CcSEcCtD
Efavirenz—Muscular weakness—Fluorouracil—head and neck cancer	0.0015	0.00479	CcSEcCtD
Efavirenz—Angiopathy—Hydroxyurea—head and neck cancer	0.00148	0.00473	CcSEcCtD
Efavirenz—Ill-defined disorder—Vinblastine—head and neck cancer	0.00145	0.00462	CcSEcCtD
Efavirenz—Alopecia—Hydroxyurea—head and neck cancer	0.00144	0.00461	CcSEcCtD
Efavirenz—Anaemia—Vinblastine—head and neck cancer	0.00144	0.0046	CcSEcCtD
Efavirenz—Erythema—Hydroxyurea—head and neck cancer	0.00142	0.00454	CcSEcCtD
Efavirenz—Thrombophlebitis—Docetaxel—head and neck cancer	0.00142	0.00453	CcSEcCtD
Efavirenz—Malaise—Vinblastine—head and neck cancer	0.00141	0.00449	CcSEcCtD
Efavirenz—Vertigo—Vinblastine—head and neck cancer	0.0014	0.00448	CcSEcCtD
Efavirenz—Pancytopenia—Fluorouracil—head and neck cancer	0.00139	0.00446	CcSEcCtD
Efavirenz—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00136	0.00436	CcSEcCtD
Efavirenz—Hepatic failure—Docetaxel—head and neck cancer	0.00136	0.00436	CcSEcCtD
Efavirenz—Cardiac failure congestive—Docetaxel—head and neck cancer	0.00135	0.00432	CcSEcCtD
Efavirenz—Convulsion—Vinblastine—head and neck cancer	0.00135	0.00432	CcSEcCtD
Efavirenz—Hypertension—Vinblastine—head and neck cancer	0.00135	0.0043	CcSEcCtD
Efavirenz—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00134	0.00428	CcSEcCtD
Efavirenz—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00132	0.00421	CcSEcCtD
Efavirenz—Pneumonia—Fluorouracil—head and neck cancer	0.00132	0.00421	CcSEcCtD
Efavirenz—Anaemia—Hydroxyurea—head and neck cancer	0.00131	0.0042	CcSEcCtD
Efavirenz—Discomfort—Vinblastine—head and neck cancer	0.00131	0.00419	CcSEcCtD
Efavirenz—Hot flush—Docetaxel—head and neck cancer	0.00131	0.00419	CcSEcCtD
Efavirenz—Infestation—Fluorouracil—head and neck cancer	0.00131	0.00418	CcSEcCtD
Efavirenz—Infestation NOS—Fluorouracil—head and neck cancer	0.00131	0.00418	CcSEcCtD
Efavirenz—Menopausal symptoms—Docetaxel—head and neck cancer	0.0013	0.00415	CcSEcCtD
Efavirenz—Renal impairment—Docetaxel—head and neck cancer	0.00129	0.00412	CcSEcCtD
Efavirenz—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00128	0.0041	CcSEcCtD
Efavirenz—Dermatitis bullous—Docetaxel—head and neck cancer	0.00128	0.0041	CcSEcCtD
Efavirenz—Malaise—Hydroxyurea—head and neck cancer	0.00128	0.0041	CcSEcCtD
Efavirenz—Thrombocytopenia—Vinblastine—head and neck cancer	0.00125	0.00398	CcSEcCtD
Efavirenz—Convulsion—Hydroxyurea—head and neck cancer	0.00123	0.00394	CcSEcCtD
Efavirenz—Sinusitis—Fluorouracil—head and neck cancer	0.00123	0.00393	CcSEcCtD
Efavirenz—Anorexia—Vinblastine—head and neck cancer	0.00121	0.00388	CcSEcCtD
Efavirenz—Migraine—Docetaxel—head and neck cancer	0.00121	0.00386	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.0012	0.00384	CcSEcCtD
Efavirenz—Discomfort—Hydroxyurea—head and neck cancer	0.0012	0.00382	CcSEcCtD
Efavirenz—Rhinitis—Fluorouracil—head and neck cancer	0.00118	0.00377	CcSEcCtD
Efavirenz—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00117	0.00374	CcSEcCtD
Efavirenz—Ataxia—Docetaxel—head and neck cancer	0.00115	0.00368	CcSEcCtD
Efavirenz—Paraesthesia—Vinblastine—head and neck cancer	0.00114	0.00365	CcSEcCtD
Efavirenz—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00114	0.00364	CcSEcCtD
Efavirenz—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00114	0.00363	CcSEcCtD
Efavirenz—Skin disorder—Hydroxyurea—head and neck cancer	0.00113	0.0036	CcSEcCtD
Efavirenz—Breast disorder—Docetaxel—head and neck cancer	0.00111	0.00354	CcSEcCtD
Efavirenz—Anorexia—Hydroxyurea—head and neck cancer	0.00111	0.00353	CcSEcCtD
Efavirenz—Decreased appetite—Vinblastine—head and neck cancer	0.00111	0.00353	CcSEcCtD
Efavirenz—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.0011	0.00353	CcSEcCtD
Efavirenz—Nasopharyngitis—Docetaxel—head and neck cancer	0.0011	0.0035	CcSEcCtD
Efavirenz—Constipation—Vinblastine—head and neck cancer	0.00109	0.00348	CcSEcCtD
Efavirenz—Pain—Vinblastine—head and neck cancer	0.00109	0.00348	CcSEcCtD
Efavirenz—Arrhythmia—Fluorouracil—head and neck cancer	0.00105	0.00336	CcSEcCtD
Efavirenz—Feeling abnormal—Vinblastine—head and neck cancer	0.00105	0.00335	CcSEcCtD
Efavirenz—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00104	0.00332	CcSEcCtD
Efavirenz—Alopecia—Fluorouracil—head and neck cancer	0.00104	0.00332	CcSEcCtD
Efavirenz—Dyspnoea—Hydroxyurea—head and neck cancer	0.00103	0.00331	CcSEcCtD
Efavirenz—Somnolence—Hydroxyurea—head and neck cancer	0.00103	0.0033	CcSEcCtD
Efavirenz—Erythema—Fluorouracil—head and neck cancer	0.00102	0.00327	CcSEcCtD
Efavirenz—Dyspepsia—Hydroxyurea—head and neck cancer	0.00102	0.00326	CcSEcCtD
Efavirenz—Decreased appetite—Hydroxyurea—head and neck cancer	0.00101	0.00322	CcSEcCtD
Efavirenz—Pancytopenia—Docetaxel—head and neck cancer	0.00101	0.00322	CcSEcCtD
Efavirenz—Abdominal pain—Vinblastine—head and neck cancer	0.00101	0.00321	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.001	0.0032	CcSEcCtD
Efavirenz—Fatigue—Hydroxyurea—head and neck cancer	0.001	0.0032	CcSEcCtD
Efavirenz—Constipation—Hydroxyurea—head and neck cancer	0.000992	0.00317	CcSEcCtD
Efavirenz—Pain—Hydroxyurea—head and neck cancer	0.000992	0.00317	CcSEcCtD
Efavirenz—Vision blurred—Fluorouracil—head and neck cancer	0.000964	0.00308	CcSEcCtD
Efavirenz—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000956	0.00306	CcSEcCtD
Efavirenz—Pneumonia—Docetaxel—head and neck cancer	0.00095	0.00304	CcSEcCtD
Efavirenz—Anaemia—Fluorouracil—head and neck cancer	0.000945	0.00302	CcSEcCtD
Efavirenz—Infestation NOS—Docetaxel—head and neck cancer	0.000945	0.00302	CcSEcCtD
Efavirenz—Infestation—Docetaxel—head and neck cancer	0.000945	0.00302	CcSEcCtD
Efavirenz—Hypersensitivity—Vinblastine—head and neck cancer	0.000937	0.003	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000937	0.00299	CcSEcCtD
Efavirenz—Renal failure—Docetaxel—head and neck cancer	0.000929	0.00297	CcSEcCtD
Efavirenz—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000926	0.00296	CcSEcCtD
Efavirenz—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.000924	0.0303	CbGpPWpGaD
Efavirenz—Jaundice—Docetaxel—head and neck cancer	0.000921	0.00294	CcSEcCtD
Efavirenz—Body temperature increased—Hydroxyurea—head and neck cancer	0.000917	0.00293	CcSEcCtD
Efavirenz—Asthenia—Vinblastine—head and neck cancer	0.000912	0.00292	CcSEcCtD
Efavirenz—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000893	0.00286	CcSEcCtD
Efavirenz—Convulsion—Fluorouracil—head and neck cancer	0.000886	0.00283	CcSEcCtD
Efavirenz—Chest pain—Fluorouracil—head and neck cancer	0.000871	0.00278	CcSEcCtD
Efavirenz—Myalgia—Fluorouracil—head and neck cancer	0.000871	0.00278	CcSEcCtD
Efavirenz—Diarrhoea—Vinblastine—head and neck cancer	0.00087	0.00278	CcSEcCtD
Efavirenz—Discomfort—Fluorouracil—head and neck cancer	0.00086	0.00275	CcSEcCtD
Efavirenz—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000854	0.00273	CcSEcCtD
Efavirenz—Rhinitis—Docetaxel—head and neck cancer	0.00085	0.00272	CcSEcCtD
Efavirenz—Hepatitis—Docetaxel—head and neck cancer	0.000848	0.00271	CcSEcCtD
Efavirenz—CYP1A2—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000845	0.0277	CbGpPWpGaD
Efavirenz—Hypoaesthesia—Docetaxel—head and neck cancer	0.000844	0.0027	CcSEcCtD
Efavirenz—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.000843	0.0276	CbGpPWpGaD
Efavirenz—Confusional state—Fluorouracil—head and neck cancer	0.000842	0.00269	CcSEcCtD
Efavirenz—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.000841	0.0276	CbGpPWpGaD
Efavirenz—Dizziness—Vinblastine—head and neck cancer	0.000841	0.00269	CcSEcCtD
Efavirenz—Urinary tract disorder—Docetaxel—head and neck cancer	0.000838	0.00268	CcSEcCtD
Efavirenz—Oedema peripheral—Docetaxel—head and neck cancer	0.000835	0.00267	CcSEcCtD
Efavirenz—Connective tissue disorder—Docetaxel—head and neck cancer	0.000833	0.00266	CcSEcCtD
Efavirenz—Asthenia—Hydroxyurea—head and neck cancer	0.000832	0.00266	CcSEcCtD
Efavirenz—Urethral disorder—Docetaxel—head and neck cancer	0.000831	0.00266	CcSEcCtD
Efavirenz—Nervous system disorder—Fluorouracil—head and neck cancer	0.000819	0.00262	CcSEcCtD
Efavirenz—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000817	0.00261	CcSEcCtD
Efavirenz—Visual impairment—Docetaxel—head and neck cancer	0.000817	0.00261	CcSEcCtD
Efavirenz—Tachycardia—Fluorouracil—head and neck cancer	0.000815	0.0026	CcSEcCtD
Efavirenz—Vomiting—Vinblastine—head and neck cancer	0.000809	0.00258	CcSEcCtD
Efavirenz—Erythema multiforme—Docetaxel—head and neck cancer	0.000802	0.00256	CcSEcCtD
Efavirenz—Headache—Vinblastine—head and neck cancer	0.000797	0.00255	CcSEcCtD
Efavirenz—Anorexia—Fluorouracil—head and neck cancer	0.000796	0.00254	CcSEcCtD
Efavirenz—Diarrhoea—Hydroxyurea—head and neck cancer	0.000794	0.00254	CcSEcCtD
Efavirenz—Eye disorder—Docetaxel—head and neck cancer	0.000793	0.00253	CcSEcCtD
Efavirenz—Cardiac disorder—Docetaxel—head and neck cancer	0.000787	0.00252	CcSEcCtD
Efavirenz—Flushing—Docetaxel—head and neck cancer	0.000787	0.00252	CcSEcCtD
Efavirenz—Angiopathy—Docetaxel—head and neck cancer	0.000769	0.00246	CcSEcCtD
Efavirenz—Dizziness—Hydroxyurea—head and neck cancer	0.000767	0.00245	CcSEcCtD
Efavirenz—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.000767	0.0252	CbGpPWpGaD
Efavirenz—Immune system disorder—Docetaxel—head and neck cancer	0.000766	0.00245	CcSEcCtD
Efavirenz—Mediastinal disorder—Docetaxel—head and neck cancer	0.000764	0.00244	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000761	0.00243	CcSEcCtD
Efavirenz—Arrhythmia—Docetaxel—head and neck cancer	0.000758	0.00242	CcSEcCtD
Efavirenz—Nausea—Vinblastine—head and neck cancer	0.000755	0.00241	CcSEcCtD
Efavirenz—Insomnia—Fluorouracil—head and neck cancer	0.000755	0.00241	CcSEcCtD
Efavirenz—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000751	0.0246	CbGpPWpGaD
Efavirenz—Paraesthesia—Fluorouracil—head and neck cancer	0.00075	0.0024	CcSEcCtD
Efavirenz—Alopecia—Docetaxel—head and neck cancer	0.000749	0.0024	CcSEcCtD
Efavirenz—Dyspnoea—Fluorouracil—head and neck cancer	0.000744	0.00238	CcSEcCtD
Efavirenz—Somnolence—Fluorouracil—head and neck cancer	0.000742	0.00237	CcSEcCtD
Efavirenz—Malnutrition—Docetaxel—head and neck cancer	0.000738	0.00236	CcSEcCtD
Efavirenz—Erythema—Docetaxel—head and neck cancer	0.000738	0.00236	CcSEcCtD
Efavirenz—Vomiting—Hydroxyurea—head and neck cancer	0.000737	0.00236	CcSEcCtD
Efavirenz—Dyspepsia—Fluorouracil—head and neck cancer	0.000735	0.00235	CcSEcCtD
Efavirenz—Rash—Hydroxyurea—head and neck cancer	0.000731	0.00234	CcSEcCtD
Efavirenz—Dermatitis—Hydroxyurea—head and neck cancer	0.000731	0.00234	CcSEcCtD
Efavirenz—Headache—Hydroxyurea—head and neck cancer	0.000727	0.00232	CcSEcCtD
Efavirenz—Decreased appetite—Fluorouracil—head and neck cancer	0.000726	0.00232	CcSEcCtD
Efavirenz—Dysgeusia—Docetaxel—head and neck cancer	0.000723	0.00231	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000721	0.0023	CcSEcCtD
Efavirenz—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00072	0.0236	CbGpPWpGaD
Efavirenz—Back pain—Docetaxel—head and neck cancer	0.000714	0.00228	CcSEcCtD
Efavirenz—Pain—Fluorouracil—head and neck cancer	0.000714	0.00228	CcSEcCtD
Efavirenz—Nausea—Hydroxyurea—head and neck cancer	0.000689	0.0022	CcSEcCtD
Efavirenz—Feeling abnormal—Fluorouracil—head and neck cancer	0.000688	0.0022	CcSEcCtD
Efavirenz—Anaemia—Docetaxel—head and neck cancer	0.000682	0.00218	CcSEcCtD
Efavirenz—Urticaria—Fluorouracil—head and neck cancer	0.000663	0.00212	CcSEcCtD
Efavirenz—Syncope—Docetaxel—head and neck cancer	0.000662	0.00212	CcSEcCtD
Efavirenz—Body temperature increased—Fluorouracil—head and neck cancer	0.00066	0.00211	CcSEcCtD
Efavirenz—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.000655	0.0215	CbGpPWpGaD
Efavirenz—Palpitations—Docetaxel—head and neck cancer	0.000652	0.00209	CcSEcCtD
Efavirenz—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000652	0.0214	CbGpPWpGaD
Efavirenz—Loss of consciousness—Docetaxel—head and neck cancer	0.000649	0.00207	CcSEcCtD
Efavirenz—Cough—Docetaxel—head and neck cancer	0.000644	0.00206	CcSEcCtD
Efavirenz—Convulsion—Docetaxel—head and neck cancer	0.00064	0.00204	CcSEcCtD
Efavirenz—Hypertension—Docetaxel—head and neck cancer	0.000637	0.00204	CcSEcCtD
Efavirenz—Arthralgia—Docetaxel—head and neck cancer	0.000629	0.00201	CcSEcCtD
Efavirenz—Chest pain—Docetaxel—head and neck cancer	0.000629	0.00201	CcSEcCtD
Efavirenz—Myalgia—Docetaxel—head and neck cancer	0.000629	0.00201	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000624	0.002	CcSEcCtD
Efavirenz—Hypersensitivity—Fluorouracil—head and neck cancer	0.000615	0.00197	CcSEcCtD
Efavirenz—Dry mouth—Docetaxel—head and neck cancer	0.000615	0.00196	CcSEcCtD
Efavirenz—Confusional state—Docetaxel—head and neck cancer	0.000608	0.00194	CcSEcCtD
Efavirenz—Shock—Docetaxel—head and neck cancer	0.000593	0.00189	CcSEcCtD
Efavirenz—Nervous system disorder—Docetaxel—head and neck cancer	0.000591	0.00189	CcSEcCtD
Efavirenz—Pruritus—Fluorouracil—head and neck cancer	0.000591	0.00189	CcSEcCtD
Efavirenz—Thrombocytopenia—Docetaxel—head and neck cancer	0.00059	0.00189	CcSEcCtD
Efavirenz—Tachycardia—Docetaxel—head and neck cancer	0.000588	0.00188	CcSEcCtD
Efavirenz—CYP2B6—Xenobiotics—CYP1A1—head and neck cancer	0.000588	0.0193	CbGpPWpGaD
Efavirenz—Skin disorder—Docetaxel—head and neck cancer	0.000585	0.00187	CcSEcCtD
Efavirenz—Anorexia—Docetaxel—head and neck cancer	0.000574	0.00184	CcSEcCtD
Efavirenz—Diarrhoea—Fluorouracil—head and neck cancer	0.000571	0.00183	CcSEcCtD
Efavirenz—Dizziness—Fluorouracil—head and neck cancer	0.000552	0.00176	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000549	0.00175	CcSEcCtD
Efavirenz—Insomnia—Docetaxel—head and neck cancer	0.000545	0.00174	CcSEcCtD
Efavirenz—Paraesthesia—Docetaxel—head and neck cancer	0.000541	0.00173	CcSEcCtD
Efavirenz—Dyspnoea—Docetaxel—head and neck cancer	0.000537	0.00172	CcSEcCtD
Efavirenz—Somnolence—Docetaxel—head and neck cancer	0.000536	0.00171	CcSEcCtD
Efavirenz—Vomiting—Fluorouracil—head and neck cancer	0.000531	0.0017	CcSEcCtD
Efavirenz—Dyspepsia—Docetaxel—head and neck cancer	0.00053	0.0017	CcSEcCtD
Efavirenz—Rash—Fluorouracil—head and neck cancer	0.000526	0.00168	CcSEcCtD
Efavirenz—Dermatitis—Fluorouracil—head and neck cancer	0.000526	0.00168	CcSEcCtD
Efavirenz—Decreased appetite—Docetaxel—head and neck cancer	0.000524	0.00167	CcSEcCtD
Efavirenz—Headache—Fluorouracil—head and neck cancer	0.000523	0.00167	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00052	0.00166	CcSEcCtD
Efavirenz—Fatigue—Docetaxel—head and neck cancer	0.000519	0.00166	CcSEcCtD
Efavirenz—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000517	0.017	CbGpPWpGaD
Efavirenz—Pain—Docetaxel—head and neck cancer	0.000515	0.00165	CcSEcCtD
Efavirenz—Constipation—Docetaxel—head and neck cancer	0.000515	0.00165	CcSEcCtD
Efavirenz—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.000506	0.0166	CbGpPWpGaD
Efavirenz—Feeling abnormal—Docetaxel—head and neck cancer	0.000497	0.00159	CcSEcCtD
Efavirenz—Nausea—Fluorouracil—head and neck cancer	0.000496	0.00159	CcSEcCtD
Efavirenz—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000493	0.00157	CcSEcCtD
Efavirenz—CYP1A2—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.000488	0.016	CbGpPWpGaD
Efavirenz—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000488	0.016	CbGpPWpGaD
Efavirenz—Body temperature increased—Docetaxel—head and neck cancer	0.000476	0.00152	CcSEcCtD
Efavirenz—Abdominal pain—Docetaxel—head and neck cancer	0.000476	0.00152	CcSEcCtD
Efavirenz—CYP2C19—Xenobiotics—CYP1A1—head and neck cancer	0.000444	0.0146	CbGpPWpGaD
Efavirenz—Hypersensitivity—Docetaxel—head and neck cancer	0.000444	0.00142	CcSEcCtD
Efavirenz—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000442	0.0145	CbGpPWpGaD
Efavirenz—Asthenia—Docetaxel—head and neck cancer	0.000432	0.00138	CcSEcCtD
Efavirenz—CYP2C19—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000427	0.014	CbGpPWpGaD
Efavirenz—Pruritus—Docetaxel—head and neck cancer	0.000426	0.00136	CcSEcCtD
Efavirenz—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000414	0.0136	CbGpPWpGaD
Efavirenz—Diarrhoea—Docetaxel—head and neck cancer	0.000412	0.00132	CcSEcCtD
Efavirenz—CYP2D6—Xenobiotics—CYP1A1—head and neck cancer	0.000408	0.0134	CbGpPWpGaD
Efavirenz—CYP2C9—Xenobiotics—CYP1A1—head and neck cancer	0.000405	0.0133	CbGpPWpGaD
Efavirenz—Dizziness—Docetaxel—head and neck cancer	0.000398	0.00127	CcSEcCtD
Efavirenz—CYP1A2—Estrogen metabolism—GSTM1—head and neck cancer	0.000397	0.013	CbGpPWpGaD
Efavirenz—CYP2D6—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000393	0.0129	CbGpPWpGaD
Efavirenz—CYP2C9—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000389	0.0128	CbGpPWpGaD
Efavirenz—Vomiting—Docetaxel—head and neck cancer	0.000383	0.00122	CcSEcCtD
Efavirenz—Rash—Docetaxel—head and neck cancer	0.00038	0.00121	CcSEcCtD
Efavirenz—Dermatitis—Docetaxel—head and neck cancer	0.00038	0.00121	CcSEcCtD
Efavirenz—Headache—Docetaxel—head and neck cancer	0.000377	0.00121	CcSEcCtD
Efavirenz—CYP1A2—Estrogen metabolism—CYP1A1—head and neck cancer	0.000376	0.0123	CbGpPWpGaD
Efavirenz—Nausea—Docetaxel—head and neck cancer	0.000358	0.00114	CcSEcCtD
Efavirenz—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.000346	0.0113	CbGpPWpGaD
Efavirenz—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000341	0.0112	CbGpPWpGaD
Efavirenz—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000333	0.0109	CbGpPWpGaD
Efavirenz—CYP2C19—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.00033	0.0108	CbGpPWpGaD
Efavirenz—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000319	0.0105	CbGpPWpGaD
Efavirenz—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000306	0.0101	CbGpPWpGaD
Efavirenz—CYP2D6—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000303	0.00995	CbGpPWpGaD
Efavirenz—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.00029	0.00953	CbGpPWpGaD
Efavirenz—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000267	0.00876	CbGpPWpGaD
Efavirenz—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000257	0.00843	CbGpPWpGaD
Efavirenz—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000257	0.00842	CbGpPWpGaD
Efavirenz—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000244	0.008	CbGpPWpGaD
Efavirenz—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000241	0.0079	CbGpPWpGaD
Efavirenz—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.000226	0.00743	CbGpPWpGaD
Efavirenz—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.000226	0.00741	CbGpPWpGaD
Efavirenz—CYP2B6—Biological oxidations—NAT2—head and neck cancer	0.000224	0.00736	CbGpPWpGaD
Efavirenz—CYP2B6—Metapathway biotransformation—NAT2—head and neck cancer	0.000221	0.00726	CbGpPWpGaD
Efavirenz—CYP2C19—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000215	0.00707	CbGpPWpGaD
Efavirenz—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000213	0.007	CbGpPWpGaD
Efavirenz—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000198	0.00649	CbGpPWpGaD
Efavirenz—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000196	0.00645	CbGpPWpGaD
Efavirenz—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000195	0.00638	CbGpPWpGaD
Efavirenz—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000184	0.00605	CbGpPWpGaD
Efavirenz—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000182	0.00597	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000178	0.00583	CbGpPWpGaD
Efavirenz—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000178	0.00583	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000178	0.00583	CbGpPWpGaD
Efavirenz—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00017	0.00556	CbGpPWpGaD
Efavirenz—CYP2C19—Biological oxidations—NAT2—head and neck cancer	0.00017	0.00556	CbGpPWpGaD
Efavirenz—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000168	0.00551	CbGpPWpGaD
Efavirenz—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000168	0.00551	CbGpPWpGaD
Efavirenz—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000167	0.00549	CbGpPWpGaD
Efavirenz—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	0.000167	0.00549	CbGpPWpGaD
Efavirenz—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000166	0.00545	CbGpPWpGaD
Efavirenz—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000166	0.00544	CbGpPWpGaD
Efavirenz—CYP2D6—Biological oxidations—NAT2—head and neck cancer	0.000156	0.00512	CbGpPWpGaD
Efavirenz—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.000155	0.00507	CbGpPWpGaD
Efavirenz—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	0.000154	0.00505	CbGpPWpGaD
Efavirenz—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000152	0.005	CbGpPWpGaD
Efavirenz—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000149	0.0049	CbGpPWpGaD
Efavirenz—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000144	0.00471	CbGpPWpGaD
Efavirenz—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000142	0.00465	CbGpPWpGaD
Efavirenz—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000137	0.00451	CbGpPWpGaD
Efavirenz—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000137	0.0045	CbGpPWpGaD
Efavirenz—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000136	0.00447	CbGpPWpGaD
Efavirenz—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.000132	0.00433	CbGpPWpGaD
Efavirenz—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.00013	0.00427	CbGpPWpGaD
Efavirenz—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000127	0.00416	CbGpPWpGaD
Efavirenz—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000116	0.00382	CbGpPWpGaD
Efavirenz—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000116	0.00379	CbGpPWpGaD
Efavirenz—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.000112	0.00366	CbGpPWpGaD
Efavirenz—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000111	0.00364	CbGpPWpGaD
Efavirenz—CYP2B6—Biological oxidations—GSTM1—head and neck cancer	0.000111	0.00364	CbGpPWpGaD
Efavirenz—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000109	0.00359	CbGpPWpGaD
Efavirenz—CYP2B6—Metapathway biotransformation—GSTM1—head and neck cancer	0.000109	0.00359	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000106	0.00347	CbGpPWpGaD
Efavirenz—CYP2B6—Biological oxidations—CYP1A1—head and neck cancer	0.000105	0.00345	CbGpPWpGaD
Efavirenz—CYP2B6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000104	0.0034	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000102	0.00335	CbGpPWpGaD
Efavirenz—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000101	0.0033	CbGpPWpGaD
Efavirenz—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	9.88e-05	0.00324	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	9.79e-05	0.00321	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—UROD—head and neck cancer	9.24e-05	0.00303	CbGpPWpGaD
Efavirenz—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	8.99e-05	0.00295	CbGpPWpGaD
Efavirenz—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	8.37e-05	0.00275	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	8.32e-05	0.00273	CbGpPWpGaD
Efavirenz—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	8.26e-05	0.00271	CbGpPWpGaD
Efavirenz—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	7.94e-05	0.0026	CbGpPWpGaD
Efavirenz—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	7.83e-05	0.00257	CbGpPWpGaD
Efavirenz—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	7.7e-05	0.00253	CbGpPWpGaD
Efavirenz—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	7.64e-05	0.00251	CbGpPWpGaD
Efavirenz—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	7.6e-05	0.00249	CbGpPWpGaD
Efavirenz—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	7.53e-05	0.00247	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	7.49e-05	0.00246	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	7.49e-05	0.00246	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	7.49e-05	0.00246	CbGpPWpGaD
Efavirenz—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	7.3e-05	0.0024	CbGpPWpGaD
Efavirenz—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	7.24e-05	0.00237	CbGpPWpGaD
Efavirenz—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	7.2e-05	0.00236	CbGpPWpGaD
Efavirenz—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	7.14e-05	0.00234	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—UROD—head and neck cancer	6.98e-05	0.00229	CbGpPWpGaD
Efavirenz—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	6.53e-05	0.00214	CbGpPWpGaD
Efavirenz—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	6.44e-05	0.00211	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—UROD—head and neck cancer	6.42e-05	0.00211	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—UROD—head and neck cancer	6.37e-05	0.00209	CbGpPWpGaD
Efavirenz—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	6.19e-05	0.00203	CbGpPWpGaD
Efavirenz—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	6.1e-05	0.002	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	6.01e-05	0.00197	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—UROD—head and neck cancer	5.44e-05	0.00179	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	5.42e-05	0.00178	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	5.04e-05	0.00165	CbGpPWpGaD
Efavirenz—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	4.97e-05	0.00163	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.94e-05	0.00162	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	4.77e-05	0.00157	CbGpPWpGaD
Efavirenz—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	4.71e-05	0.00154	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.22e-05	0.00138	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—UROD—head and neck cancer	4.2e-05	0.00138	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—NAT2—head and neck cancer	3.84e-05	0.00126	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—DPYD—head and neck cancer	3.36e-05	0.0011	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—YAP1—head and neck cancer	3.19e-05	0.00105	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.08e-05	0.00101	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.05e-05	0.001	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—NAT2—head and neck cancer	2.9e-05	0.000951	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.81e-05	0.000921	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.78e-05	0.000912	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—NAT2—head and neck cancer	2.67e-05	0.000875	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—NAT2—head and neck cancer	2.64e-05	0.000867	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—DPYD—head and neck cancer	2.54e-05	0.000834	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—YAP1—head and neck cancer	2.41e-05	0.000792	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.4e-05	0.000787	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.38e-05	0.000779	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—DPYD—head and neck cancer	2.34e-05	0.000767	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—DPYD—head and neck cancer	2.32e-05	0.000761	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NAT2—head and neck cancer	2.26e-05	0.000741	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—YAP1—head and neck cancer	2.22e-05	0.000728	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—YAP1—head and neck cancer	2.2e-05	0.000722	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—DPYD—head and neck cancer	1.98e-05	0.00065	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—TYMS—head and neck cancer	1.92e-05	0.000629	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GSTM1—head and neck cancer	1.9e-05	0.000622	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—YAP1—head and neck cancer	1.88e-05	0.000617	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GPX1—head and neck cancer	1.82e-05	0.000595	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.81e-05	0.000595	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CYP1A1—head and neck cancer	1.8e-05	0.000589	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NAT2—head and neck cancer	1.74e-05	0.000572	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.65e-05	0.000542	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.58e-05	0.000519	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—DPYD—head and neck cancer	1.53e-05	0.000502	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—YAP1—head and neck cancer	1.45e-05	0.000476	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—TYMS—head and neck cancer	1.45e-05	0.000475	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.44e-05	0.000473	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTM1—head and neck cancer	1.43e-05	0.00047	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.41e-05	0.000463	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GPX1—head and neck cancer	1.37e-05	0.00045	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP1A1—head and neck cancer	1.36e-05	0.000445	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—TYMS—head and neck cancer	1.33e-05	0.000437	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—TYMS—head and neck cancer	1.32e-05	0.000433	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTM1—head and neck cancer	1.32e-05	0.000432	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTM1—head and neck cancer	1.31e-05	0.000428	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GPX1—head and neck cancer	1.26e-05	0.000414	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GPX1—head and neck cancer	1.25e-05	0.00041	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP1A1—head and neck cancer	1.25e-05	0.00041	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP1A1—head and neck cancer	1.24e-05	0.000406	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.23e-05	0.000404	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—TYMS—head and neck cancer	1.13e-05	0.00037	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTM1—head and neck cancer	1.12e-05	0.000366	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.12e-05	0.000366	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GPX1—head and neck cancer	1.07e-05	0.000351	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PTGS2—head and neck cancer	1.07e-05	0.000351	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP1A1—head and neck cancer	1.06e-05	0.000347	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.02e-05	0.000334	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PTEN—head and neck cancer	9.32e-06	0.000306	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—TYMS—head and neck cancer	8.71e-06	0.000286	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.69e-06	0.000285	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTM1—head and neck cancer	8.61e-06	0.000283	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GPX1—head and neck cancer	8.25e-06	0.000271	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP1A1—head and neck cancer	8.16e-06	0.000268	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PTGS2—head and neck cancer	8.07e-06	0.000265	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PTGS2—head and neck cancer	7.43e-06	0.000244	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PTGS2—head and neck cancer	7.36e-06	0.000242	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PTEN—head and neck cancer	7.04e-06	0.000231	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CA—head and neck cancer	6.57e-06	0.000216	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PTEN—head and neck cancer	6.48e-06	0.000212	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PTEN—head and neck cancer	6.42e-06	0.000211	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PTGS2—head and neck cancer	6.29e-06	0.000206	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PTEN—head and neck cancer	5.49e-06	0.00018	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—AKT1—head and neck cancer	5.37e-06	0.000176	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CA—head and neck cancer	4.97e-06	0.000163	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PTGS2—head and neck cancer	4.86e-06	0.000159	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CA—head and neck cancer	4.57e-06	0.00015	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CA—head and neck cancer	4.53e-06	0.000149	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PTEN—head and neck cancer	4.23e-06	0.000139	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—AKT1—head and neck cancer	4.06e-06	0.000133	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CA—head and neck cancer	3.87e-06	0.000127	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—AKT1—head and neck cancer	3.73e-06	0.000122	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—AKT1—head and neck cancer	3.7e-06	0.000121	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—AKT1—head and neck cancer	3.16e-06	0.000104	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CA—head and neck cancer	2.99e-06	9.8e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—AKT1—head and neck cancer	2.44e-06	8.01e-05	CbGpPWpGaD
